What moved ASCN.SW stock higher today?

ASCN.SW stock rose **8.94%** on 22 Jan 2026 on above-average volume (278,786). The move aligned with healthcare sector strength and positioning ahead of the company’s earnings on 2026-03-09.

How does Ascom’s valuation compare to peers?

Ascom shows a high trailing **PE ~64.75** and price/sales **~0.65**, while the Swiss healthcare sector average PE is lower. The company’s free cash flow yield near **14.78%** offsets some valuation concerns.

What is Meyka AI’s view on ASCN.SW stock?

Meyka AI rates ASCN.SW **68.66/100 (B, HOLD)** and projects a quarterly model level of **CHF 4.94**. The grade accounts for benchmarks, sector, growth and metrics. Forecasts are model-based and not guarantees.

When is Ascom’s next earnings report and why it matters?

Ascom’s next earnings announcement is scheduled for **2026-03-09**. Results will be key for EPS visibility (current EPS **CHF 0.08**) and will likely drive volatility given the stock’s high PE.

CH Stocks

ASCN.SW Ascom Holding AG (SIX) up 8.94% 22 Jan 2026: market closed, analyst outlook

ByHuzaifa Zahoor January 23, 2026

The ASCN.SW stock led Swiss healthcare gainers on 22 Jan 2026, closing at CHF 5.18, up 8.94% on heavy trade. Volume hit 278,786 shares versus a 50-day average of 86,530, signalling strong intraday buyer interest. Ascom Holding AG (ASCN.SW) outpaced the Healthcare sector 1D move of +1.01%, driven by positive flows into clinical workflow and device names. We review the drivers, valuation, technical setup, Meyka AI grade and a short-term forecast for traders and investors.